Ge Zhu

968 total citations · 1 hit paper
34 papers, 766 citations indexed

About

Ge Zhu is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Ge Zhu has authored 34 papers receiving a total of 766 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Immunology and 6 papers in Cancer Research. Recurrent topics in Ge Zhu's work include RNA Interference and Gene Delivery (4 papers), Immunotherapy and Immune Responses (4 papers) and Nanoplatforms for cancer theranostics (4 papers). Ge Zhu is often cited by papers focused on RNA Interference and Gene Delivery (4 papers), Immunotherapy and Immune Responses (4 papers) and Nanoplatforms for cancer theranostics (4 papers). Ge Zhu collaborates with scholars based in China, United States and Saint Kitts and Nevis. Ge Zhu's co-authors include Feng Li, Tianmeng Sun, Jialiang Wang, Qiang Ke, Juan Wang, Jianxun Ding, Zhongmin Li, Weiguo Xu, Di Li and Jia-Zhen Yang and has published in prestigious journals such as Advanced Materials, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Ge Zhu

29 papers receiving 760 citations

Hit Papers

A Tumor Microenvironments‐Adapted Polypeptide Hydrogel/Na... 2022 2026 2023 2024 2022 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ge Zhu China 14 388 187 173 155 114 34 766
Shan Guan China 19 796 2.1× 156 0.8× 149 0.9× 134 0.9× 113 1.0× 51 1.2k
Fu‐Fei Hsu Taiwan 11 316 0.8× 161 0.9× 113 0.7× 117 0.8× 57 0.5× 15 636
Arnab Ghosh United States 18 445 1.1× 131 0.7× 201 1.2× 103 0.7× 183 1.6× 27 746
Chun‐Mei Hu Taiwan 16 395 1.0× 138 0.7× 225 1.3× 109 0.7× 160 1.4× 48 778
Zhao Yang China 16 341 0.9× 148 0.8× 243 1.4× 145 0.9× 95 0.8× 35 907
Yu Xi China 15 371 1.0× 122 0.7× 212 1.2× 89 0.6× 206 1.8× 27 1.0k
Pichet Adstamongkonkul United States 6 261 0.7× 178 1.0× 252 1.5× 141 0.9× 55 0.5× 8 786
Yi Jin China 14 507 1.3× 138 0.7× 111 0.6× 135 0.9× 352 3.1× 36 872

Countries citing papers authored by Ge Zhu

Since Specialization
Citations

This map shows the geographic impact of Ge Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ge Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ge Zhu more than expected).

Fields of papers citing papers by Ge Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ge Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ge Zhu. The network helps show where Ge Zhu may publish in the future.

Co-authorship network of co-authors of Ge Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Ge Zhu. A scholar is included among the top collaborators of Ge Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ge Zhu. Ge Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhu, Ge, et al.. (2025). Brain-wide connections of the parvicellular subdivision of the basolateral and basomedial amygdaloid nuclei in the rats. Frontiers in Neural Circuits. 19. 1575232–1575232.
3.
Uddin, Md Alim, Yiqun Geng, Li Wang, et al.. (2025). Metal-free nitroxide-containing T1 magnetic resonance imaging contrast agent for invasive breast cancer diagnosis. European Polymer Journal. 239. 114303–114303. 2 indexed citations
4.
Mao, Kuirong, Xiuxiu Cong, Ji Liu, et al.. (2024). Optimized lipid nanoparticles enable effective CRISPR/Cas9-mediated gene editing in dendritic cells for enhanced immunotherapy. Acta Pharmaceutica Sinica B. 15(1). 642–656. 7 indexed citations
6.
Xiang, Xiaojun, et al.. (2024). Comparison of the connectivity of the posterior intralaminar thalamic nucleus and peripeduncular nucleus in rats and mice. Frontiers in Neural Circuits. 18. 1384621–1384621. 6 indexed citations
7.
Zhang, Zhuojun, Jinyuan Pan, Ping Zhou, et al.. (2023). Peptidase inhibitor (PI16) impairs bladder cancer metastasis by inhibiting NF-κB activation via disrupting multiple-site ubiquitination of NEMO. Cellular & Molecular Biology Letters. 28(1). 62–62. 4 indexed citations
8.
Zhu, Ge, Zhihan Li, Yuning Zhang, et al.. (2023). Biosafety risk assessment of gold and aluminum nanoparticles in tumor-bearing mice. APL Bioengineering. 7(1). 16116–16116. 3 indexed citations
9.
Meng, Xiandi, Kuirong Mao, Hongmei Chen, et al.. (2023). Maleimide as the PEG end-group promotes macrophage-targeted drug delivery of PEGylated nanoparticles in vivo by enhancing interaction with circulating erythrocytes. Biomaterials. 300. 122187–122187. 20 indexed citations
10.
Li, Zhongmin, Weiguo Xu, Jia-Zhen Yang, et al.. (2022). A Tumor Microenvironments‐Adapted Polypeptide Hydrogel/Nanogel Composite Boosts Antitumor Molecularly Targeted Inhibition and Immunoactivation. Advanced Materials. 34(21). e2200449–e2200449. 145 indexed citations breakdown →
11.
Zhu, Ge, et al.. (2021). A global grid model for the vertical correction of zenith wet delay based on the sliding window algorithm. SHILAP Revista de lepidopterología. 5 indexed citations
12.
He, Yanpu, Celestine Hong, Ge Zhu, et al.. (2020). Self-assembled cGAMP-STINGΔTM signaling complex as a bioinspired platform for cGAMP delivery. Science Advances. 6(24). eaba7589–eaba7589. 42 indexed citations
13.
Chen, Hongmei, Xiuxiu Cong, Chenxi Wu, et al.. (2020). Intratumoral delivery of CCL25 enhances immunotherapy against triple-negative breast cancer by recruiting CCR9 + T cells. Science Advances. 6(5). eaax4690–eaax4690. 70 indexed citations
14.
Zhang, Xia, Yang Li, Yangguang Shao, et al.. (2017). PAK4 regulates G6PD activity by p53 degradation involving colon cancer cell growth. Cell Death and Disease. 8(5). e2820–e2820. 51 indexed citations
15.
Zhu, Ge, Li Xu, Bingyu Guo, et al.. (2015). PAK5-mediated E47 phosphorylation promotes epithelial–mesenchymal transition and metastasis of colon cancer. Oncogene. 35(15). 1943–1954. 35 indexed citations
16.
Fu, Min, et al.. (2015). Mathematical model and error analysis of light intensity orthogonal modulation type displacement sensor. Optics and Precision Engineering. 23(3). 784–793.
17.
Li, Yang, Qiang Ke, Yangguang Shao, et al.. (2015). GATA1 induces epithelial-mesenchymal transition in breast cancer cells through PAK5 oncogenic signaling. Oncotarget. 6(6). 4345–4356. 44 indexed citations
18.
Chen, W-T, Ge Zhu, Kyle T. Pfaffenbach, et al.. (2013). GRP78 as a regulator of liver steatosis and cancer progression mediated by loss of the tumor suppressor PTEN. Oncogene. 33(42). 4997–5005. 64 indexed citations
19.
Zhu, Ge, et al.. (2012). Astragalus Polysaccharides Enhance Cellular Immune Response and Disease Resistance in Yellow Catfish. Israeli Journal of Aquaculture - Bamidgeh. 64. 18 indexed citations
20.
Liu, Tong, Yang Li, Hui Gu, et al.. (2012). p21-activated Kinase 6 (PAK6) Inhibits Prostate Cancer Growth via Phosphorylation of Androgen Receptor and Tumorigenic E3 Ligase Murine Double Minute-2 (Mdm2). Journal of Biological Chemistry. 288(5). 3359–3369. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026